Cargando…
Targeting IFNGR/IL6R or downstream JAK1/JAK2 to control GvHD
Autores principales: | Ashami, Kidist, DiPersio, John F., Choi, Jaebok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254668/ https://www.ncbi.nlm.nih.gov/pubmed/30515263 http://dx.doi.org/10.18632/oncotarget.26291 |
Ejemplares similares
-
Pharmacologic Blockade of JAK1/JAK2 Reduces GvHD and Preserves the Graft-Versus-Leukemia Effect
por: Choi, Jaebok, et al.
Publicado: (2014) -
Editorial: Interferons and GvHD
por: Kim, Boram, et al.
Publicado: (2022) -
Inflammasome effects in GvHD
por: Koehn, Brent H., et al.
Publicado: (2015) -
Antibody- and aptamer-strategies for GvHD prevention
por: Oelkrug, Christopher, et al.
Publicado: (2015) -
Established and Emerging Treatments of Skin GvHD
por: Link-Rachner, Cornelia S., et al.
Publicado: (2022)